RAC
Click for more information
0.58% $1.74 race oncology ltd

Ann: Bisantrene Preclinical Drug Study Published, page-3

  1. IndexInvestor
    8,416 Posts.
    lightbulb Created with Sketch. 1385
    clock Created with Sketch.
    10/05/21
    10:34
    Post #: 53057120
    Hi @RaceOncology

    Three or more of the nucleoside analogs plus bisantrene gives the highest synergy in preclinical.

    IIRC only two nucleoside analogs plus bisantrene are proposed for the Israel trial.

    Why only two?

    Let me guess, legal reasons.
    Last edited by IndexInvestor: 10/05/21
    RAC Price at posting: $3.40 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AGY Argosy signs deal to sell battery-grade Rincon lithium to Korea
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.74 		Change
0.010(0.58%) 		Mkt cap ! $295.5M
Open High Low Value Volume
$1.76 $1.77 $1.60 $400.7K 236.4K

Buyers (Bids)

No. Vol. Price($)
1 550 $1.67
 

Sellers (Offers)

Price($) Vol. No.
$1.75 400 1
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.